The vaginal ring (NuvaRing^®) for contraception in adolescent women

References

• Bitzer J , Tschudin S , Frey Tirri B . Kontrazeption bei Adoleszentinnen. S. Praxisarena 2007;4:21–27.
   Google Scholar
• NuvaRing® Product Description.
   Google Scholar
• Dieben TO , Roumen FJ , Apter D . Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 2002;100:585–593.
   PubMed Web of Science ®Google Scholar
• Oddsson K , Leifels-Fischer B , de Melo NR , Wiel-Masson D , Benedetto C , Verhoeven CH , Dieben TO . Efficacy and safety of a contraceptive vaginal ring (NuvaRing®) compared with a combined oral contraceptive: a 1-year randomized trial. Contraception 2005;71:176–182.
   PubMed Web of Science ®Google Scholar
• Roumen FJ . Review of the combined contraceptive vaginal ring, NuvaRing. Ther Clin Risk Manag 2008;4:441–451.
   PubMedGoogle Scholar
• Dogterom P , van den Heuvel MW , Thomsen T . Absence of pharmacokinetic interactions of the combined contraceptive vaginal ring NuvaRing® with oral amoxicillin or doxycycline in two randomised trials. Clin Pharmacokinet 2005;44:429–438.
   PubMed Web of Science ®Google Scholar
• Stewart FH , Brown BA , Rain TR , Weitz TA , Harper CC . Adolescent and young women's experience with the vaginal ring and oral contraceptive pills. Adolesc Pediatric Gyn 2007;20:345–351.
   Google Scholar
• Carey AS , Chiappetta L , Tremont K , Murray PJ , Gold MA . The contraceptive vaginal ring: female adolescents' knowledge, attitudes and plans for use. Contraception 2007;766:444–450.
   Google Scholar
• Gilliam ML , Neustadt A , Kozloski M , Mistretta S , Tilmon S , Godfrey E . Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial. Obstet Gynecol 2010;115:503–510.
   PubMed Web of Science ®Google Scholar
• Roy S , Wilkins J , Mishell DR Jr . The effect of a contraceptive vaginal ring and oral contraceptives on the vaginal flora. Contraception 1981;24:481–491.
   PubMed Web of Science ®Google Scholar
• Davies GC , Feng LX , Newton JR , Dieben TO , Coelingh-Bennink HJ . The effects of a combined contraceptive vaginal ring releasing ethinyloestradiol and 3-ketodesogestrel on vaginal flora. Contraception 1992;45:511–518.
   PubMed Web of Science ®Google Scholar
• Veres S , Miller L , Burington B . A comparison between the vaginal ring and oral contraceptives. Obstet Gynecol 2004;104:555–563.
   PubMed Web of Science ®Google Scholar
• Camacho DP , Consolaro ME , Patussi EV , Donatti L , Gasparetto A , Svidzinski TI . Vaginal yeast adherence to the combined contraceptive vaginal ring (CCVR). Contraception 2007;76:439–443.
   PubMed Web of Science ®Google Scholar
• Verhoeven CH , van den Heuvel MW , Mulders TM , Dieben TO . The contraceptive vaginal ring, NuvaRing®, and antimycotic co-medication. Contraception 2004;69:129–132.
   PubMed Web of Science ®Google Scholar
• Verhoeven CH , Dieben TO . The combined contraceptive vaginal ring, NuvaRing®, and tampon co-usage. Contraception 2004;69:197–199.
   PubMed Web of Science ®Google Scholar
• Haring T , Mulders TM . The combined contraceptive ring NuvaRing® and spermicide co-medication. Contraception 2003;67:271–272.
   PubMed Web of Science ®Google Scholar
• Jensen JT , Burke AE , Barnhart KT , Tillotson C , Messerle-Forbes M , Peters D . Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis. Contraception 2008;78:451–458.
   PubMed Web of Science ®Google Scholar
• Massaro M , Di Carlo C , Gargano V , Formisano C , Bifulco G , Nappi C . Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study. Contraception 2010;81:209–214.
   PubMed Web of Science ®Google Scholar
• Milsom I , Lete I , Bjertnaes A , Rokstad K , Lindh I , Gruber CJ , Birkhäuser MH , Aubeny E , Knudsen T , Bastianelli E . Effects on cycle control and bodyweight of the combined contraceptive ring, NuvaRing®, versus an oral contraceptive containing 30 microg ethinyl estradiol and 3 mg drospirenone. Hum Reprod 2006;21:2304–2311.
   PubMed Web of Science ®Google Scholar
• Ahrendt HJ , Nisand I , Bastianelli C , Gómez MA , Gemzell-Danielsson K , Urdl W , Karskov B , Oeyen L , Bitzer J , Page G , et al. Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing®, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.
   Google Scholar
• Oddsson K , Leifels-Fischer B , Wiel-Masson D , de Melo NR , Benedetto C , Verhoeven CH , Dieben TO . Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial. Hum Reprod 2005;20:557–562. Epub 2001 Nov 11.
   PubMed Web of Science ®Google Scholar
• Bjarnadottir RI , Tuppurainen M , Killick SR . Comparison of cycle control with a combined contraceptive vaginal ring and oral levonorgestrel/ethinyl estradiol. Am J Obstet Gynecol 2002;186:389–395.
   PubMed Web of Science ®Google Scholar
• Westhoff C , Osborne LM , Schafer JE , Morroni C . Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive. Obstet Gynecol 2005;106:89–96.
   PubMed Web of Science ®Google Scholar
• Sabatini R , Cagiano R . Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Contraception 2006;74:220–223.
   PubMed Web of Science ®Google Scholar
• Merki-Feld GS , Hund M . Clinical experience with NuvaRing® in daily practice in Switzerland: cycle control and acceptability among women of all reproductive ages. Eur J Contracept Reprod Health Care 2007;12:240–247.
   PubMed Web of Science ®Google Scholar
• Merki-Feld GS , Hund M . Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use. Eur J Contracept Reprod Health Care 2010;15:413–422.
   PubMed Web of Science ®Google Scholar
• Sulak PJ , Smith V , Coffee A , Witt I , Kuehl AL , Kuehl TJ . Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial. Obstet Gynecol 2008;112:563–571.
   PubMed Web of Science ®Google Scholar
• Gracia CR , Sammel MD , Charlesworth S , Lin H , Barnhart KT , Creinin MD . Sexual function in first-time contraceptive ring and contraceptive patch users. Fertil Steril 2010;93:21–28.
   PubMed Web of Science ®Google Scholar